Project Grant R21AR084126
Award Date
9/20/24
Completion Date
8/31/26
Dollars Obligated
$783K
Awardee
Mayo Clinic (Y2K4F9RPRRG7)
Federal Grant Program
93.846
Assistance Type
Project Grant
Place of Performance
Minnesota, USA
Similar Awards
The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded a $765,546 Project Grant under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846) to The Regents of the University of California, San Francisco (UCSF). The grant supports the development of a non-invasive "virtual bone biopsy" approach using high-resolution peripheral quantitative computed tomography (HR-PQCT) to assess bone turnover in patients with chronic kidney...
The National Institute of Biomedical Imaging and Bioengineering (NIBIB) awarded a $546,874 Project Grant under the "Discovery and Applied Research for Technological Innovations to Improve Human Health" (CFDA 93.286) program to Mayo Clinic. The grant, effective from April 1, 2025 to January 31, 2029, supports the development and validation of an AI-assisted quantitative photon-counting-detector CT (PCD-CT) imaging protocol for cytogenetic risk stratification and treatment response...
The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded a $483,070 Project Grant (CFDA 93.846 - Arthritis, Musculoskeletal and Skin Diseases Research) to the University of Missouri at Kansas City (UMKC) to conduct research on the dynamics of bone extracellular matrix (ECM) assembly and resorption. The research aims to determine how osteogenic cellular dynamics, differentiation, and cell fate are integrated with collagen assembly and mineralization dynamics, as...
This federal Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), will fund a research project titled "Bone Quality Assessment During Breast Cancer Treatment via Wrist Tomosynthesis in the Mammography Setting". The $651,514 award will be provided to a collaborative research partnership between Henry Ford Health and Michigan State University...
This $456,808 federal Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846) is supporting the development of innovative mass spectrometry imaging (MSI) technologies to spatially visualize proteins and glycans in musculoskeletal tissues. The primary awardee, the Buck Institute for Research on Aging, is collaborating with researchers at the University of...
This federal Project Grant award, totaling $279,354, was provided by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846). The award will fund research to evaluate the use of denosumab and sequential zoledronic acid therapy to prevent bone loss after acute spinal cord injury (SCI). Key activities include initiating clinical, operational and regulatory activities; developing a data...
This federal Project Grant award in the amount of $375,100.00, awarded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), supports research into the cellular mechanisms of age-associated cortical bone remodeling. The two-year deliverables of the proposed study are: 1) identification of myeloid progenitors that aid in maintenance of cortical bone with age, and 2)...
This federal Project Grant award, valued at $322,408 and provided by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), supports research under CFDA program 93.846 - Arthritis, Musculoskeletal and Skin Diseases Research. The research aims to define how mechanically-evoked calcium signaling across 3D osteocyte networks in bone modulates the spatiotemporal remodeling of osteoblasts and osteoclasts in normal and injured conditions. The project will utilize a novel...
This federal Project Grant award of $239,488 from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846) will fund research to characterize the inflammatory pathologies underlying axial psoriatic arthritis (AxPsA). The University of California, Davis will utilize total-body positron emission tomography/computed tomography (TB-PET/CT) imaging to investigate the dominant spinal...
This federal Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), provides $599,693 to support research into the negative regulation of osteoclastogenesis - the process of generating bone-resorbing cells. The overarching goals are to elucidate the molecular pathways and mechanisms that regulate myeloid cell function and osteoclastogenesis under...